PSI Hero banner 1920x450

2024 Conference Sessions

Session presentations can be found below. They are listed by date and session title, with slide decks available to download beneath.
Please note: these are only accessible for PSI Members, and you will need to be signed in to access them.

 

Monday 17 June

Keynote
Geert Meulenbergs - Biostatistics in a post-pandemic era

Estimands for time-to-event outcomes
1. Looking back on our estimands in oncology working group journey - Evgeny Degtyarev
2. Re-Thinking treatment effect measure in clinical trials with time-to-event outcomes and competing risks- Tobias Mutze
3. Outcome of Survey on Current Standards and Implementation of Covariate Adjusted and Stratified Analyses - Sarwar Mozumder
4. Can the Estimand framework help improve the analysis of adverse events of special interest - Pedro Lopez Romero

Biomarkers ESIG
Biomarkers ESIG - Advancing Biomarker Insights in Precision Medicine and Digital Health

Patient Focused Drug Development (PFDD) SIG: Hot Topics
1. Patient Focused Drug Development Hot Topics - Rachael Lawrance
2. PFDD - Konstantina Skaltsa
3. PFDD - Emerging Patient-Centric Tolerability Endpoints - John Devin Peipert
4. PFDD Patient Focussed Digital Health Technology - Piper Fromy

How to Generate Evidence from Real World Data
1. Transforming RWD into RWE overview
2. External control cohorts for the single-arm LIBRETTO-001 trial - Min Hua Jen

Causal inference and estimands
1. Targetted maximum likelihood estimation - Bob Murray
2. Estimand in Formulation Studies - Insight from IMscin trial - Mahesh Shivhare
3. Estimands and complex innovative designs - Olivier Collignon
4. Causal inference and estimands - Yongming Qu

Data Visualization and animation
1. How to draw a really bad graph - Chris Harbron
2. Digital accessibility - Ursula Becker
3. Data Story Telling - Bodo Kirsch

HTA
1. Enhanced subgroup identification in heterogeneous clinical courses of disease burden using a machine learning score from CT images - Grace Kim
2. Developing Trial-Based Risk Prediction Models - Milans Ivkovic and Martin Bog
3. Open source workflows for HTA - Anders Gorst-Rasmussen
4. Censoring and choice of Tau in Quality Adjusted Time Without Symptoms of Toxicity - Saiful Islam and Grace Antony

CYS2
1. Enhancing Variable Importance Interpretation - Ahmad Chamma
2. Time patterns of repeat non-fatal events and death in heart failure trials - Audinga-Dea Hazewinkel
3. Rise n Shiny - Taking steps to utilise R packages in Shiny applications - Emily Foreman
4. Accounting for the recruitment process - Marco Ratta


Tuesday 18 June

Keynote
Theo Smith - Neurodiversity at work

Quantitative Decision Making in Drug Development
1. Simple approaches for portfolio quantitative decision-making session - Gaelle Saint-Hilary
2. Simple approaches for portfolio quantitative decision-making session - Rosalind Hobson
3. Simple approaches for portfolio quantitative decision-making session - Wei Quan

Bias in indirect treatment comparisons and evolving methodology
Bias in indirect treatment comparisons and evolving methodology - HTA ESIG

Bridging the gap between Bayesian & frequentist adaptive designs
1. Forecasting with Confidence - Harnessing Predictive Probabilities in - Adaptive Clinical Trial Design - Cora Allen-Savietta
2. Adaptations Interim Analyses and Multiplicity in Clinical Trials - Franz Koenig
3. Regulatory considerations on complex clinical trials and adaptive designs with Bayesian design elements - Benjamin Hofner

Advancements in Digital Health Technology
1. Advancements in Digital Health Technology - Suzanne Schaefer
2. Advancements in Digital Health Technology - Mia Tackey
3. Advancements in Digital Health Technology - Rosemary Abbott 


Wednesday 19 June

Bayesian Borrowing
1. Bayesian Borrowing - Carl-Fredrik Burman
2. Bayesian Borrowing - Danila Azzolina
3. Bayesian Borrowing -  Erik Hermansson

Decision Making
1. Detriment Index based Ranking Technique for painkiller drugs in Noncommunicable Diseases - Samadhan Ghubade
2. Assurance methods for designing a survival trial with a delayed treatment effect - James Salsbury
3. Application of Quantitative Decision Making in Early Clinical Development - Nicola Scott

Non Technical TED Talks
1. Unveiling the Power of Public Speaking to Statisticians - Guillaume Desachy
2. Empowering Newcomers - Kristina Weber
3. Emotional Intelligence for the Statistically Brilliant - Emma May
4. Learning Lessons - Sam Ruddell
5. Stats Drugs and RocknRoll - Patrik Atkinson
6. The Ukrainian experience - Angelina Rozmarytsia

Technical TED Talks
1. Evaluating Re-Identification Risks scores in Publicly Available Clinical Trial Datasets - Aryelly Rodriguez
2. Expert judgement to support a clinical hybrid Bayesian network approach on pancreatic cancer - Erica Secchettin
3. A Conservative Approach to Leveraging Prior Evidence about Treatment Effects for Effective Group Sequential Clinical Trial Design - Fabio Rigat
4. Conditional-Power-Induced Migraine - Simon Cleall
5. To Master Protocol or Not To Master Protocol - Elizabeth Pilling
6. Stat-GPT – AI for Statisticians in the Pharmaceutical Industry - Sam Hadlington

CYS
1. REMoDLing Phase II trial to incorporate historical information on a time-to-event endpoint - Alessandra Serra
2. Practical Challenges in Real World Evidence Studies - Andisheh Bakhshi
3. Controlled multiple imputation in time-to-event data using tipping point analysis - Daniel Clement
4. Investigating the impact of Data Monitoring Committee recommendations on the probability of trial success Luca Rondano
5. Dual criteria approach to early Accelerated Approval in time-to-event group sequential trials via historical borrowing - Marco Ratta

Upcoming Events